Loading...
Thumbnail Image
Publication

MCV-miR-M1 targets the host-cell immune response resulting in the attenuation of neutrophil chemotaxis

Akhbari, Pouria
Tobin, Desmond J.
Roberts, W.
Boyne, James R.
Publication Date
2018-11
End of Embargo
Supervisor
Rights
© 2018 Elsevier. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2018-03-29
Institution
Department
Awarded
Embargo end date
Additional title
Abstract
Virus-encoded miRNAs are emerging as key regulators of persistent infection and host-cell immune evasion. Merkel cell polyomavirus (MCPyV), the predominant aetiological agent of Merkel cell carcinoma (MCC), encodes a single miRNA, MCV-miR-M1, which targets the oncogenic MCPyV large T antigen (LT). MCV-miR-M1 has previously been shown to play an important role in establishment of long-term infection, however, the underlying mechanism is not fully understood. A key unanswered question is whether, in addition to auto-regulating LT, MCV-miR-M1 also targets cellular transcripts to orchestrate an environment conducive for persistent infection. To address this, we adopted an RNA-Seq-based approach to identify cellular targets of MCV-miR-M1. Intriguingly, bioinformatics analysis of transcripts that are differentially expressed in cells expressing MCV-miR-M1 revealed several genes implicated in immune evasion. Subsequent target validation led to the identification of the innate immunity protein, SP100, as a direct target of MCV-miR-M1. Moreover, MCV-miR-M1-mediated modulation of SP100 was associated with a significant decrease in CXCL8 secretion, resulting in the attenuation of neutrophil chemotaxis towards Merkel cells harbouring synthetic MCPyV. Based on these observations we propose that MCV-miR-M1 targets key immune response regulators to help facilitate persistent infection, which is a pre-requisite for cellular transformation in MCC.
Version
Accepted manuscript
Citation
Akhbari P, Tobin D, Poterlowicz K et al (2018) MCV-miR-M1 targets the host-cell immune response resulting in the attenuation of neutrophil chemotaxis. Journal of Investigative Dermatology. 138(11): 2343-2354.
Link to publisher’s version
Link to published version
Type
Article
Qualification name
Notes